Clinical Trial Update: 18F-FDG PET Metabolic Phenotype in Evaluating Therapeutic Response for Breast Cancer Patients With Bone Metastases.

View source ↗

Summary

A clinical trial update evaluating whether 18F-FDG PET metabolic phenotype can assess therapeutic response in breast cancer patients with bone metastases; curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Breast Cancer, 18F-FDG PET | Status: UNKNOWN